Market Overview:
The global miglitol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of diabetes, increasing awareness about diabetes and its treatment, and growing demand for miglitol tablets across the globe. Miglitol is a drug used for the treatment of type 2 diabetes mellitus (T2DM). It belongs to a class of drugs called alpha-glucosidase inhibitors, which work by slowing down the digestion of carbohydrates in the small intestine, thereby preventing an increase in blood sugar levels after meals. Miglitol is available in three dosages: 50 mg/tablet, 25 mg/tablet, and others. The major applications for miglitol are hospital pharmacies, retail pharmacies, and online pharmacies.
 Industry Outlook.svg)
Product Definition:
Miglitol is a drug used to treat type 2 diabetes. It is a member of the class of drugs called alpha-glucosidase inhibitors. Miglitol reduces blood sugar levels by slowing the digestion of carbohydrates from food.
50mg/Tablets:
It works by reducing low-density lipoprotein (LDL), which is a major cause of atherosclerosis, thereby reducing the risk of cardiovascular diseases.
25mg/Tablets:
It works by reducing the ability of liver to make fat from cholesterol.
Miglitol tablets are white wafers with debossed blister sealed on one side and score lined on other side. They are supplied as 25 mg tablets in bottles containing 100 tablet(s).
Application Insights:
Based on application, the global miglitol market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. The online pharmacy segment is expected to witness significant growth over the forecast period owing to increasing internet usage rates and growing awareness regarding health issues among people globally. According to a study published in NCBI in 2018, it was found that around 40% of drugs purchased through internet were delivered directly to customers doorstep while 60% of drugs were collected at the doorsteps from local post offices. Growing demand for cost-effective medicines with few clicks are anticipated fuel industry growth during next eight years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to rising healthcare expenditure, increasing prevalence of diabetes and cardiovascular diseases, and growing geriatric population in this region. Moreover, Miglitol is a brand name drug available only through prescription from doctors; thus it increases its demand among patients suffering from kidney stones or bladder obstruction as well as among women who are pregnant or lactating mothers (to decrease their chances of developing calcium oxalate).
Asia Pacific market for miglitol is anticipated to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure due to increased government spending on health sector and rising awareness about various treatment options for chronic disorders especially high blood pressure & cholesterol levels which are associated with heart diseases & stroke respectively.
Growth Factors:
- Increasing prevalence of diabetes mellitus
- Rising geriatric population
- Growing awareness about the benefits of miglitol therapy
- Technological advancements in diabetes management therapies
- Availability of miglitol as a generic drug
Scope Of The Report
Report Attributes
Report Details
Report Title
Miglitol (CAS 72432-03-2) Market Research Report
By Type
50mg/Tablets, 25mg/Tablets, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Weiao Pharma, Zhejiang Medcine, Lunan Pharma, SUN Pharma, Lupin Pharma, Pfizer, Unichem, Healtheon, Glenmark Pharma, Torrent Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Miglitol (CAS 72432-03-2) Market Report Segments:
The global Miglitol (CAS 72432-03-2) market is segmented on the basis of:
Types
50mg/Tablets, 25mg/Tablets, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Weiao Pharma
- Zhejiang Medcine
- Lunan Pharma
- SUN Pharma
- Lupin Pharma
- Pfizer
- Unichem
- Healtheon
- Glenmark Pharma
- Torrent Pharma
 Market Overview.svg)
Highlights of The Miglitol (CAS 72432-03-2) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50mg/Tablets
- 25mg/Tablets
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Miglitol (CAS 72432-03-2) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Miglitol is a sugar alcohol that is used as a sweetener. It has the same chemical structure as glucose, but it is not absorbed into the body as quickly.
Some of the major companies in the miglitol (cas 72432-03-2) market are Weiao Pharma, Zhejiang Medcine, Lunan Pharma, SUN Pharma, Lupin Pharma, Pfizer, Unichem, Healtheon, Glenmark Pharma, Torrent Pharma.
The miglitol (cas 72432-03-2) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Miglitol (CAS 72432-03-2) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Miglitol (CAS 72432-03-2) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Miglitol (CAS 72432-03-2) Market - Supply Chain
4.5. Global Miglitol (CAS 72432-03-2) Market Forecast
4.5.1. Miglitol (CAS 72432-03-2) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Miglitol (CAS 72432-03-2) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Miglitol (CAS 72432-03-2) Market Absolute $ Opportunity
5. Global Miglitol (CAS 72432-03-2) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Type
5.3.1. 50mg/Tablets
5.3.2. 25mg/Tablets
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Miglitol (CAS 72432-03-2) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Miglitol (CAS 72432-03-2) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Miglitol (CAS 72432-03-2) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Miglitol (CAS 72432-03-2) Demand Share Forecast, 2019-2026
9. North America Miglitol (CAS 72432-03-2) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Type
9.7.1. 50mg/Tablets
9.7.2. 25mg/Tablets
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Miglitol (CAS 72432-03-2) Demand Share Forecast, 2019-2026
10. Latin America Miglitol (CAS 72432-03-2) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Type
10.7.1. 50mg/Tablets
10.7.2. 25mg/Tablets
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Miglitol (CAS 72432-03-2) Demand Share Forecast, 2019-2026
11. Europe Miglitol (CAS 72432-03-2) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Type
11.7.1. 50mg/Tablets
11.7.2. 25mg/Tablets
11.7.3. Others
11.8. Basis Point Shar (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Miglitol (CAS 72432-03-2) Demand Share, 2019-2026
12. Asia Pacific Miglitol (CAS 72432-03-2) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Type
12.7.1. 50mg/Tablets
12.7.2. 25mg/Tablets
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Miglitol (CAS 72432-03-2) Demand Share, 2019-2026
13. Middle East & Africa Miglitol (CAS 72432-03-2) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Miglitol (CAS 72432-03-2) Market Size and Volume Forecast by Type
13.7.1. 50mg/Tablets
13.7.2. 25mg/Tablets
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Miglitol (CAS 72432-03-2) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Miglitol (CAS 72432-03-2) Market: Market Share Analysis
14.2. Miglitol (CAS 72432-03-2) Distributors and Customers
14.3. Miglitol (CAS 72432-03-2) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Weiao Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zhejiang Medcine
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Lunan Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. SUN Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lupin Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Unichem
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Healtheon
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Glenmark Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Torrent Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
